Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial biofilms and microbial cell membranes are fundamental structural components that serve as primary targets for antimicrobial agents. The microbial cell membrane is a lipid bilayer that maintains cellular integrity and regulates the transport of ions and nutrients (Epand, R. M., et al., 2016, Biochimica et Biophysica Acta). Bacterial biofilms are organized communities of microorganisms embedded in a self-produced extracellular polymeric substance (EPS) matrix, which provides a physical barrier against environmental stressors (Donlan, R. M., 2002, Emerging Infectious Diseases). These structures play a significant role in disease by facilitating chronic infections and providing high levels of resistance to both host immune responses and traditional antibiotics (Hall-Stoodley, L., et al., 2004, Nature Reviews Microbiology). Therapeutic agents like daptomycin and polymyxins target the cell membrane by inducing depolarization or physical disruption, leading to cell lysis (Heidary, M., et al., 2018, Journal of Cellular Physiology). Biofilm-specific therapies aim to degrade the EPS matrix or interfere with quorum sensing to disperse the microbial community and restore antibiotic sensitivity (Roy, R., et al., 2018, Virulence). Challenges in targeting these structures include the potential for host cell toxicity and the difficulty of achieving effective drug concentrations within the dense biofilm architecture. Understanding the molecular composition of these targets is essential for developing next-generation treatments for multidrug-resistant infections.
Disruption of lipid bilayer integrity, pore formation, degradation of extracellular polymeric substances (EPS), inhibition of quorum sensing, and physical detachment of the biofilm matrix.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial biofilm and microbial cell membrane.